Lisa Harrington

Faraz Siddiqui is speaking at Medicaid Drug Rebate Program SummitSeptember 19th, 2023
Riette van Laack is speaking at ACC’s Nutrition Law SymposiumSeptember 8th, 2023
Fourteen HP&M Attorneys Recognized by Best Lawyers® in 2024 in AmericaAugust 25th, 2023
August 25, 2023 Hyman, Phelps & McNamara, P.C. (“HP&M”) is is proud to announce that 14 of the Firm’s attorneys have been selected to the 2024 edition of The Best Lawyers in America®. Newly recognized this year are attorneys Josephine M. Torrente (FDA Law), Michelle L. Butler (FDA Law), Sara W. …
Subgroup analyses and pre-specificationAugust 1st, 2023
Large clinical trials provide the opportunity to assess treatment effects in subgroups of patients, based on baseline demographic and disease-related factors, and there is always great interest in these analyses. Generally, the term “pre-specification” has major ramifications for clinical trials, particularly for adequate and well-controlled …
Larry Houck is speaking at the 2023 Opioid Abuse Management SummitJuly 20th, 2023
Riette van Laack is speaking at IFT FIRST Short Course: Labeling Requirements and Implications for Food Marketed in the U.S.July 15th, 2023
Xuebijing Injection for the Treatment of Sepsis: What Would a Path to FDA Approval Look LikeJuly 1st, 2023
Ricardo Carvajal is speaking at ACI’s Legal, Regulatory & Compliance Forum on Dietary SupplementsJune 28th, 2023
Charles Raver is speaking at DIA 2023 Global Annual Meeting – ILLUMINATEJune 28th, 2023
James Valentine is speaking at DIA 2023 Global Annual Meeting – ILLUMINATEJune 28th, 2023
Anne Walsh is Co-Chair of the International Bar Association’s World Life Science ConferenceJune 1st, 2023
HPM Webinar: Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock InspectionsMay 24th, 2023
Anne Walsh is speaking at FDLI’s 2023 Annual ConferenceMay 17th, 2023
Sophia Gaulkin is speaking at Informa Connect’s Drug Pricing Transparency CongressMay 16th, 2023
Jeff Shapiro is speaking at the Florida Medical Device SymposiumMay 3rd, 2023
FDA News Webinar: Medical Device Enforcement: Are You Up-to-Date on the Latest DevelopmentsApril 20th, 2023
Kurt Karst is speaking at ACI’s Paragraph IV Disputes: Strategies for Brand Name and GenericsApril 19th, 2023
Riette Van Laack is speaking at ACI’s Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products ConferenceMarch 28th, 2023
Ricardo Carvajal is a moderator at FDLI’s Food and Dietary Supplement Safety and Regulation Conference (Virtual Event)March 24th, 2023
Larry Houck is speaking at American Pharmacists Annual MeetingMarch 24th, 2023
HPM Webinar: The “End” of the COVID-19 Emergency: the Ryan Haight Act, Telemedicine and Next StepsMarch 23rd, 2023
Kurt Karst is Co-Chair of FDA Bootcamp – Training in Core Regulatory Concepts for Life Sciences Attorneys, Business Executives, and Policy AnalystsMarch 22nd, 2023
Riette Van Laack is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 22nd, 2023
Ricardo Carvajal is speaking at FDLI Introduction to Food Law and Regulation CourseMarch 21st, 2023
History of EFLA ∙ EFLA’s Contributions to Comparative Law: A U.S. PerspectiveMarch 4th, 2023
Doug Farquhar is speaking at Pharma Conference’s Current Hot GMP TopicsFebruary 8th, 2023
Frank Sasinowski will be panelist in Webinar: 2023 Wow! or Yeow!? FDA Outlook for 2023 and BeyondJanuary 20th, 2023
Anne Walsh is speaking at FDLI’s Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco IndustriesDecember 7th, 2022
Frank Sasinowski is speaking at the Milken Institute Partnering for Patients Forum 2022December 6th, 2022
Sara Koblitz is speaking at GRx+Bioxims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Kurt Karst is speaking at GRx+Biosims 2022 Generics and Biosimilars ConferenceNovember 8th, 2022
Anne Walsh is speaking at International Bar Association Annual ConferenceNovember 3rd, 2022
Sara Koblitz is speaking at Food and Drug Law Journal 2022 Symposium – “The Interconnected Regulatory Landscape: Exploring FDA’s Relationship with Other Domestic Regulators”November 3rd, 2022
Sara Koblitz is speaking at ACI’s Virtual Series: Hatch-Waxman and BPCIA Passport to Proficiency Series: Focus on Bioequivalence, Exclusivity, Extensions, and Exceptions;October 25th, 2022
Ricardo Carvajal is speaking at FEMA Fall SymposiumOctober 24th, 2022
Sara Koblitz is presenting at TOPRA Virtual Masterclass: Module Regulatory Strategy for Established Active SubstancesOctober 13th, 2022
Kurt Karst is speaking at World Intellectual Property ForumOctober 10th, 2022
Ricardo Carvajal is speaking at FDLI’s Food Advertising, Labeling, and Litigation Conference: For the Food and Dietary Supplement IndustriesSeptember 28th, 2022
Ricardo Carvajal is speaking at FDLI Lunch and Learn: Practicing Food Law Today: What You Must KnowSeptember 27th, 2022
Kurt Karst is speaking at ACI’s Paragraph IV Disputes Master SymposiumSeptember 21st, 2022
Deborah Livornese is participating in FDANews WebinarSeptember 15th, 2022
Kurt Karst is Co-Chair at ACI’s Virtual FDA Boot CampSeptember 14th, 2022
Adrienne Lenz is speaking at RAPS Convergence 2022September 13th, 2022
Karla Palmer is participating in FDLI WebinarAugust 30th, 2022
Riette van Laack is speaking at IFT First Annual Event and ExpoJuly 10th, 2022
Anne Walsh is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Sara Koblitz is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Ricardo Carvajal is speaking at FDLI’s Annual Conference: Exploring Advanced Topics in Food and Drug LawJune 15th, 2022
Allyson Mullen is speaking at SAGES 16th International NOSCAR Summit and Surgical Disruptive Technology SummitJune 11th, 2022
Frank Sasinowski is speaking at The United Mitochondrial Disease Foundation ConferenceJune 9th, 2022